The DOI matches its Crossref record; 30 of the 32 references it cites were found in a registry or an index.
Cellular localization of serotonin2A (5HT2A) receptors in the rat brain
Abstract
The serotonin(2A) (5HT(2A)) receptors have been shown to play an important role in several psychiatric disorders, including depression, schizophrenia, and alcoholism. This immunohistochemical study examined the cellular localization of 5HT(2A) receptors in various rat brain structures (olfactory, striatum, cortex, hippocampus, and amygdala). The colocalization of 5HT(2A) receptors in astrocytes was performed by double-immunofluorescence staining of 5HT(2A) receptors and of glial fibrillary acidic protein (GFAP) using confocal laser microscopy. 5HT(2A) receptor immunolabeling was observed in olfactory bulbs, neostriatum, hippocampus, amygdala, and neocortex. Somata and dendrites of pyramidal cells in the frontal cortex (layer V) were densely labeled with 5HT(2A) receptors. In several other brain structures (hippocampus, amygdala, striatum, olfactory structures), 5HT(2A) receptor immunolabeling was found in cell bodies and processes of neurons. 5HT(2A) receptor immunolabeling was also observed in GFAP-positive cells of the various brain structures we investigated (layers I/VI of the neocortex, corpus callosum, hippocampal fissure and hilus, and amygdala). These results indicate that 5HT(2A) receptors are expressed in neurons and astrocytes and suggest the possibility that not only neuronal but also glial 5HT(2A) receptors have functional implications in psychiatric disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In rodents, this expression pattern has been confirmed using immunohistochemistry (203–206), light and electron microscope immunocytochemistry (203), in situ hybridization (207, 208), receptor autoradiography (209), and transgenic mice expressing EGFP under control of the 5-HT2A receptor promoter (210).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [204]
Citations
Cites
Pazos, Á., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90856-x · Cited by 1,855
Pompeiano, M., Palacios, J. M., & Mengod, G. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90223-2 · Cited by 870
Long-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor Binding
Peroutka, S. J., & Snyder, S. H. (1980) · Science · doi:10.1126/science.6251550 · Cited by 837
Pazos, Á., Cortés, R., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90857-1 · Cited by 824
Zifa, E., & Fillion, G. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(01)80026-2 · Cited by 677
Principles of neural cell migration
RAKIC, P. T. (1990) · Cellular and Molecular Life Sciences · doi:10.1007/bf01939380 · Cited by 653
Jakab, R. L., & Goldman-Rakic, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.735 · Cited by 536
Peroutka, S. J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03166.x · Cited by 524
Aghajanian, G. K., & Marek, G. J. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00051-8 · Cited by 516
Arango, V. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810230054009 · Cited by 420
Cited by
Sorted by citations
Items 101–194 of 194
Serotonin Modulation of Dorsoventral Hippocampus in Physiology and Schizophrenia
Kandilakis, C. L., & Papatheodoropoulos, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157253 · Cited by 14
Jastrzębski, M. K., Wójcik, P., Grudzińska, A., Andreozzi, G., Vetrò, T., Asim, A., Mudgal, A., Czapiński, J., Wróbel, T. M., Bartuzi, D., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.002 · Cited by 15
Rajkumar, R., & Mahesh, R. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777256 · Cited by 13
Pandey, D., Bhatt, S., Jindal, A., & Gautam, B. (2014) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.144935 · Cited by 13
Piccolini, V. M., Cerri, S., Romanelli, E., & Bernocchi, G. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.12.044 · Cited by 13
Dudok, J. J., Groffen, A. J. A., Witter, M. P., Voorn, P., & Verhage, M. (2009) · Brain Research · doi:10.1016/j.brainres.2009.08.071 · Cited by 12
Mishra, A., & Goel, R. K. (2020) · Journal of Epilepsy Research · doi:10.14581/jer.19012 · Cited by 12
Zimering, M. B. (2018) · Journal of Endocrinology and Diabetes · doi:10.15226/2374-6890/5/2/00102 · Cited by 12
Regina, M. J., Winter, J. C., & Rabin, R. A. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00287-9 · Cited by 12
Collins, S. A., Huff, C., Chiaia, N. L., Gudelsky, G. A., & Yamamoto, B. K. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13493 · Cited by 12
Massé, F., Hascoët, M., & Bourin, M. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.11.002 · Cited by 12
Spaced Training Enhances Contextual Fear Memory via Activating Hippocampal 5-HT2A Receptors
Jiang, L., Wang, L., Yin, Y., Huo, M., Liu, C., Zhou, Q., Yu, D., Xu, L., & Mao, R. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00317 · Cited by 12
5-HT2A receptors are differentially expressed in bullfrog and rat retinas: A comparative study
Han, L., Zhong, Y., & Yang, X. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.04.005 · Cited by 11
Kroll, T., Elmenhorst, D., Matusch, A., Çelik, A., Wedekind, F., Weisshaupt, A., Beer, S., & Bauer, A. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2013.09.001 · Cited by 11
Mellios, N., Papageorgiou, G., Gorgievski, V., Maxson, G., Hernandez, M., Otero, M. P., Varangis, M., Dell’Orco, M., Perrone‐Bizzozero, N. I., & Tzavara, E. T. (2024) · Research Square · doi:10.21203/rs.3.rs-3547375/v1 · Cited by 11
McQueney, A. J., & Garcia, E. J. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2024.112426 · Cited by 10
Serotonergic control of excitability: from neuron to networks
Giovanni, G. D., Chagraoui, A., Bharatiya, R., & Deurwaerdère, P. D. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-444-64125-0.00010-4 · Cited by 10
Kroll, T., Elmenhorst, D., Matusch, A., Wedekind, F., Weisshaupt, A., Beer, S., & Bauer, A. (2013) · Molecular Imaging and Biology · doi:10.1007/s11307-013-0621-3 · Cited by 10
Mechanism of JCV Entry into Oligodendrocytes
Santagata, S., & Kinney, H. C. (2005) · Science · doi:10.1126/science.309.5733.381b · Cited by 10
Astrocytes modulate cerebral blood flow and neuronal response to cocaine in prefrontal cortex
Du, C., Park, K., Hua, Y., Liu, Y., Volkow, N. D., & Pan, Y. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02373-9 · Cited by 10
Horner, K. A., Gilbert, Y. E., & Noble, E. S. (2011) · Brain Research · doi:10.1016/j.brainres.2011.03.033 · Cited by 10
Wotton, C. A., Quon, E. F., Palmer, A. C., & Bekar, L. K. (2018) · Journal of Neuroendocrinology · doi:10.1111/jne.12592 · Cited by 10
Troca-Marín, J. A., & Geijo‐Barrientos, E. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0875-4 · Cited by 9
5-HT2A deletion protects against Clozapine-induced hyperglycemia
Joshi, R., Singh, S. P., & Panicker, M. M. (2018) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2018.11.015 · Cited by 9
Hippocampal Zkscan4 confers resilience to chronic stress–induced depression-like behaviors
Gao, K., Yang, Y., Sun, X., Wang, J., Sun, X., Lu, T., Wang, L., Li, M., Yue, W., Liu, H., et al. (2025) · Science Advances · doi:10.1126/sciadv.adr2291 · Cited by 8
Leitner, D., Devore, S., Laze, J., Friedman, D. J., Mills, J. D., Liu, Y., Janitz, M., Anink, J. J., Baayen, J. C., Idema, S., et al. (2022) · Epilepsia · doi:10.1111/epi.17400 · Cited by 11
Ochoa, J. G., Stolyarova, A., Kaur, A., Hart, E. E., Bugarin, A., & Izquierdo, A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00155 · Cited by 8
Russo, A., Pellitteri, R., Monaco, S., Romeo, R., & Stanzani, S. (2004) · Developmental Brain Research · doi:10.1016/j.devbrainres.2004.11.002 · Cited by 8
Jalles, A., Vieira, C., Pereira‐Sousa, J., Vilasboas‐Campos, D., Mota, A. F., Vasconcelos, S., Ferreira-Lomba, B., Costa, M. D., Silva, J. D. D., Maciel, P., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10020370 · Cited by 9
Jensen, N. (2005) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-2111 · Cited by 9
The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine
Park, D., Lee, G., Lee, W.-G., Kim, B. S., Lee, Y., & Kim, J. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03100-2 · Cited by 11
Analysis of 5-HT2A Receptor Binding with [11C]MDL 100907 in Rats: Optimization of Kinetic Modeling
Visser, A. K. D., de Vries, E. F. J., Ramakrishnan, N. K., Willemsen, A. T. M., Bosker, F. J., den Boer, J. A., Dierckx, R., & van Waarde, A. (2013) · Molecular Imaging and Biology · doi:10.1007/s11307-013-0633-z · Cited by 7
Holmes, C., McCulley, M., Nicoll, J. A. R., Alder, J. T., Chen, C., & Francis, P. T. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.04.009 · Cited by 7
Johnson, R. T., Breedlove, S. M., & Jordan, C. L. (2010) · Vitamins and hormones · doi:10.1016/s0083-6729(10)82002-3 · Cited by 8
Mohammadi, R., Jahanshahi, M., & Jameie, S. (2016) · Basic and Clinical Neuroscience Journal · doi:10.15412/j.bcn.03070310 · Cited by 7
Fountoulakis, K. Ν., Tohen, M. F., & Zarate, C. A. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.01.002 · Cited by 6
Wojtas, A., Herian, M., Maćkowiak, M., Solarz, A., Wawrzczak‐Bargieła, A., Bysiek, A., Noworyta, K., & Gołembiowska, K. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109713 · Cited by 6
Lambe, E. K., & Aghajanian, G. K. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-080-5_12 · Cited by 6
Rivastigmine Restores 5-HT1A Receptor Levels in the Hippocampus of Olfactory Bulbectomized Mice
Islam, M. R., Moriguchi, S., Tagashira, H., & Fukunaga, K. (2014) · Advances in Alzheimer s Disease · doi:10.4236/aad.2014.33012 · Cited by 6
Willmann, M., Hegger, J., Neumaier, B., & Ermert, J. (2021) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00658 · Cited by 6
A final common pathway for depression: implications for therapy
Stone, E. A. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.8.1019 · Cited by 6
Zimering, M. B., Grinberg, M., Burton, J., & Pang, K. (2020) · doi:10.31038/edmj.2020435 · Cited by 5
Pharmacology of 5-HT2 Modulation of Amygdala & Hypothalamus in Anxiety Disorders
Jiang, X., Chen, A., Smerin, S. E., Zhang, L., & Li, H. (2011) · InTech eBooks · doi:10.5772/22837 · Cited by 5
Role of Serotonin-2A Receptors in Pathophysiology and Treatment of Depression
Moravčíková, L., Csatlósová, K., Ďurišová, B., Ondáčová, K., Pavlovičová, M., Lacinová, Ľ., & Dremencov, E. (2018) · Springer eBooks · doi:10.1007/978-3-319-70474-6_9 · Cited by 5
Ou, H., Tang, J., Guo, G., Shi, M., Yang, C., & Chen, W. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114127 · Cited by 5
Zimering, M. B., & Nadkarni, S. (2019) · doi:10.31038/edmj.2019344 · Cited by 5
Laurent, L., Jean, A., Manrique, C., Najimi, M., Chigr, F., & Compan, V. (2012) · Neuromethods · doi:10.1007/978-1-62703-104-2_19 · Cited by 5
Ekoh, F., Rerrie, S., Angud, J., & Mirabelli, E. (2025) · Psychoactives · doi:10.3390/psychoactives4040039 · Cited by 4
The Interacting Neuroendocrine Network in Stress-Inducing Mood Disorders
Leff, P., Hernández, M. E., Becerril‐Villanueva, E., Martinez, C. B. D. R., Téllez-Santillán, C., Pérez-Tapia, M., Salazar, A., Antón, B., Berlanga, C., & Pavón, L. (2010) · The Open Neuroendocrinology Journal · doi:10.2174/1876528901003010180 · Cited by 5
5-HT2A Receptors in the Basal Ganglia
Miguélez, C., Morera-Herreras, T., & Deurwaerdère, P. D. (2018) · Springer eBooks · doi:10.1007/978-3-319-70474-6_12 · Cited by 2
Zimering, M. B., Delic, V., & Citron, B. A. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02428-4 · Cited by 4
Identifying the In Vivo Cellular Correlates of Antipsychotic Drugs
Joshi, R., & Panicker, M. M. (2018) · eNeuro · doi:10.1523/eneuro.0220-18.2018 · Cited by 4
Hafizi, S., Serres, F., Pei, Q., Totterdell, S., & Sharp, T. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111425969 · Cited by 3
Morais, T. P., Salamanca, G., Vaz, S. H., Sebastião, A. M., Bombardi, C., Crunelli, V., & Giovanni, G. D. (2026) · Epilepsia · doi:10.1002/epi.70272 · Cited by 2
Bombardi, C. (2018) · Springer eBooks · doi:10.1007/978-3-319-70474-6_4 · Cited by 2
Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairment
Song, J., Kambari, Y., Amaev, A., Ueno, F., Carmona, E. T., Luca, V. D., Pollock, B. G., Flint, A. J., Husain, M. I., Graff‐Guerrero, A., et al. (2023) · Medical Hypotheses · doi:10.1016/j.mehy.2023.111068 · Cited by 4
Augustine, F., Doss, S. M., Pellicciotti, J., Mahate, S., & Singer, H. S. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.01.005 · Cited by 2
Ахмадеев, А. В., & Калимуллина, Л. Б. (2013) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-012-9702-z · Cited by 2
Psychotherapy and Antidepressant Treatment Effects on the Functional Neuroanatomy of Depression
Sankar, A., & Fu, C. H. Y. (2015) · Psychopathology Review · doi:10.5127/pr.036514 · Cited by 2
Serotonin 2A (5-HT 2A) Receptor Function
Panicker, M. M., Raote, I., & Bhattacharya, A. (2007) · Frontiers in neuroscience · doi:10.1201/9781420005752.ch6 · Cited by 2
The Promise of Psychedelic Research
Peritore, C. (2022) · Future Drug Discovery · doi:10.4155/fdd-2021-0012 · Cited by 3
Kelly, T. J., & Liu, Q.-S. (2024) · Psychedelics. · doi:10.61373/pp024b.0019 · Cited by 1
Rama, R., Qi, G., Radnikow, G., Yang, D., & Feldmeyer, D. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70573 · Cited by 1
Bostancıklıoğlu, M., Kaplan, D. S., Bal, R., Yiğit, E., Ulusal, H., & Temiz, E. (2026) · Biological Psychiatry · doi:10.1016/j.biopsych.2026.01.016 · Cited by 1
Crunelli, V., Morais, T. P., Connelly, W. M., Salamanca, G., Vaz, S. H., Sebastião, A. M., Bombardi, C., & Giovanni, G. D. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111073 · Cited by 1
Serotonergic mechanisms contributing to arousal and alerting
Sanford, L. D., Ross, R. J. M., & Morrison, A. R. (2008) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8561-3_20 · Cited by 1
Class A GPCR: Serotonin Receptors
Grinde, E., & Herrick‐Davis, K. (2017) · Springer eBooks · doi:10.1007/978-3-319-60174-8_6 · Cited by 1
Erratum to: “Neural stem cells and the regulation of neurogenesis in the adult hippocampus”
Seri, B., & Álvarez-Buylla, A. (2002) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(02)00050-6 · Cited by 1
The contribution of 5-HT1A receptors in improving plasticity and function of the brain
Aguiar, R. P. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20201215rp · Cited by 1
On antidepressant effects of running and SSRI : Focus on hippocampus and striatal dopamine pathways
Bjørnebekk, A. (2007) · Figshare
INSTITUTO DE NEUROCIENCIAS "FEDERICO OLÓRIZ"
Medicina, F. D. (2008)
5HT2A Receptor Antagonist Treatment for Repetitive Behaviors and Restricted Interests in BTBR Mice
Amodeo, D. A. (2015) · Figshare
Camacho, M. B. (2018) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Exploring the Neural Underpinnings of an Antidepressant and Rewarding Action of Early Anorexia
Compan, V. (2020) · Neuromethods · doi:10.1007/978-1-0716-0924-8_17
Other Times I Can Barely See: The Effects of Hallucinogens on Vision and Attention
Baggott, M. J. (2010) · eScholarship (California Digital Library)
Herian, M., Adam, W., Maćkowiak, M., Agnieszka, B.-W., Solarz, A., Bysiek, A., Katarzyna, M., & Gołembiowska, K. (2021) · Research Square · doi:10.21203/rs.3.rs-963701/v1
Cunningham, K. A. (2007) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1070742.523664
Sun, Y., Chebolu, S., & Darmani, N. A. (2024) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000789
Dynamic Analysis of Serotonin-Regulated Neuron–Astrocyte Model for Alzheimer’s Disease
Yan, S., Yang, X., & Li, Y. (2025) · International Journal of Bifurcation and Chaos · doi:10.1142/s0218127425501883
Fisher, P. M. (2010) · D-Scholarship@Pitt (University of Pittsburgh)
Liu, Y., Clare, K. M., Jetalpuria, Y., Pan, Y., Volkow, N. D., & Du, C. (2026) · Scientific Reports · doi:10.1038/s41598-026-38521-8
Fiorillo, M., & González-Maeso, J. (2026) · BMC Neuroscience · doi:10.1186/s12868-026-01003-8
Pratlong, M. (2014) · theses.fr (ABES) · doi:10.70675/02dafa47zd1cfz49e6z86a9zb57e2f9d693f
Rôle de la D-sérine dans la modulation des synapses glutamatergiques de l'hippocampe
Bail, M. L. (2015) · theses.fr (ABES) · doi:10.70675/e5c5af98zfa6az4f78zb04fzc23c8de05a70
Tiwari, R. K., Sharma, B., Sharma, A. K., & Pandey, R. (2026) · Current Neurovascular Research · doi:10.2174/0115672026440701260331063904
Cellular mechanisms of serotonergic psychedelics - apical hypercontextualisation
Kaup, K., Jiménez, J. H., & Aru, J. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106876
Metadata
- Authors
- Xu, T., & Pandey, S. C.
- Affiliations
- University of Illinois Chicago (US)
- Corresponding author
- Pandey, Subhash C
- ORCID
- Pandey, Subhash C
- Venue
- Brain Research Bulletin
- Publisher
- Elsevier BV
- Published
- 2000-04
- Volume
- 51
- Issue
- 6
- Pages
- 499-505
- ISSN
- 0361-9230 (ISSN-L)
- OpenAlex
- W1555828690
- Cited by
- 194
- References
- 32
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 8 · 2023: 4 · 2022: 8 · 2021: 11 · 2020: 10 · 2019: 4 · 2018: 12 · 2017: 3 · 2016: 5 · 2015: 9 · 2014: 8 · 2013: 7 · 2012: 5
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain Research Bulletin (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- University of Illinois at Chicago
- National Institute on Alcohol Abuse and Alcoholism (AA 10005)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- 5-HT2A receptor, receptor localization, rat brain, astrocytes, glial fibrillary acidic protein, olfactory bulb, neostriatum, hippocampus, amygdala, neocortex, pyramidal neurons, mental illness, schizophrenia, depression, alcoholism
- MeSH terms
- Amygdala, Animals, Astrocytes, Basal Ganglia, Brain, Cerebral Cortex, Fluorescent Antibody Technique, Glial Fibrillary Acidic Protein, Hippocampus, Male, Neurons, Olfactory Pathways, Receptors, Serotonin, Rats, Sprague-Dawley, Receptor, Serotonin, 5-HT2A, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review